Networking U.S. Science By The Year 2000

Fits and starts in the drive to contruct an information age interstate highway system WASHINGTON—White House science policy analyst, Paul Huray wanted to send the latest draft of an upcoming report on advances in computer technology to members of his intergovernmental Committee on Computer Research and Applications. So he sought an electronic solution. But Huray found that the jumble of networks that now exist couldn’t do the job. Networks balked when ordered to talk to each o

Written byKris Herbst
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Fits and starts in the drive to contruct an information age interstate highway system

WASHINGTON—White House science policy analyst, Paul Huray wanted to send the latest draft of an upcoming report on advances in computer technology to members of his intergovernmental Committee on Computer Research and Applications. So he sought an electronic solution.

But Huray found that the jumble of networks that now exist couldn’t do the job. Networks balked when ordered to talk to each other. Delays stretched into the next day.

“I was using BITNET, and my fellow committee members were using NSFNET or ARPANET,” he explains. “Plus, since our document was longer than a couple of pages, it tended to get shoved aside and processed at night. Some networks broke it up into subfiles, which sometimes got scrambled by the time they arrived.”

To his disgust—and wry amusement—Huray had just proved the central thesis of his panel’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies